Pharmaceutical Manufacturing Virtual Panel – Using the Discrete Element Method (DEM) to simulate pharmaceutical manufacturing processes
- Start Date
- End Date
Join a live virtual panel presentation & discussion to hear insights from industry experts on the use of the Discrete Element Method (DEM) as a modelling tool for optimizing pharmaceutical manufacturing processes.
Speakers will take turn to discuss and share their experience and perspective around the following topics:
- Challenges faced before introducing DEM simulation and why considered/adopted
- Experience adopting DEM
- Typical DEM applications in process and product development
- Key benefits of using DEM
- Regulatory framework: using models for regulatory purposes
- Digital design / digital twin
- Looking ahead for DEM: next focus and challenges ahead
- How DEM can help fast and efficient drug development and manufacturing in the current context
- Liang Li
Process Engineering Scientist
The Janssen Pharmaceutical Companies of Johnson & Johnson
- Maitraye Sen
Senior Consultant Engineer
Eli Lilly and Company
- Nima Yazdanpanah
- Fernando Muzzio
Distinguished Professor of Chemical and Biochemical Engineering
Who should attend?
- Engineers, scientists and researchers involved in the drug product manufacturing process.
- Anyone interested to learn more about the applications of the Discrete Element Method in the pharmaceutical industry, what key insight it can provide and the benefits it can bring to optimize drug development.
Find out more about the speakers and the agenda here.